BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28215724)

  • 21. [Crizotinib treatment in a lung adenocarcinoma harboring ALK fusion gene with bone marrow metastasis: case report and literature review].
    Li X; Liu X; Gao F; Yin X
    Zhongguo Fei Ai Za Zhi; 2015 Feb; 18(2):85-8. PubMed ID: 25676401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new human lung adenocarcinoma cell line harboring the EML4-ALK fusion gene.
    Isozaki H; Yasugi M; Takigawa N; Hotta K; Ichihara E; Taniguchi A; Toyooka S; Hashida S; Sendo T; Tanimoto M; Kiura K
    Jpn J Clin Oncol; 2014 Oct; 44(10):963-8. PubMed ID: 25170107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas.
    Lantuejoul S; Rouquette I; Blons H; Le Stang N; Ilie M; Begueret H; Grégoire V; Hofman P; Gros A; Garcia S; Monhoven N; Devouassoux-Shisheboran M; Mansuet-Lupo A; Thivolet F; Antoine M; Vignaud JM; Penault-Llorca F; Galateau-Sallé F; McLeer-Florin A
    Eur Respir J; 2015 Jul; 46(1):207-18. PubMed ID: 25929957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ALK rearrangement in specific subtypes of lung adenocarcinoma: immunophenotypic and morphological features.
    Possidente L; Landriscina M; Patitucci G; Borgia L; Lalinga V; Vita G
    Med Oncol; 2017 May; 34(5):76. PubMed ID: 28364271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of crizotinib in a patient with ALK IHC-positive/FISH-negative metastatic lung adenocarcinoma.
    Rosoux A; Pauwels P; Duplaquet F; D'Haene N; Weynand B; Delos M; Menon R; Heukamp LC; Thunnissen E; Ocak S
    Lung Cancer; 2016 Aug; 98():118-121. PubMed ID: 27393517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in Immunohistochemical Protein Levels in Anaplastic Lymphoma Kinase-positive Lung Adenocarcinoma Possibly due to Chemo-radiotherapy.
    Taniguchi H; Ikeda T; Soda H; Fukuda Y; Kitazaki T; Nakamura Y; Kohno S
    Intern Med; 2016; 55(13):1775-8. PubMed ID: 27374682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemistry, fluorescence in situ hybridization, and reverse transcription-polymerase chain reaction for the detection of anaplastic lymphoma kinase gene rearrangements in patients with non-small cell lung cancer: potential advantages and methodologic pitfalls.
    Demidova I; Barinov A; Savelov N; Gagarin I; Grinevitch V; Stroiakovaski D; Popov M; Laktionov K; Gutorov S; Smolin A; Olshanskaya Y; Obukhova T
    Arch Pathol Lab Med; 2014 Jun; 138(6):794-802. PubMed ID: 24878018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anaplastic lymphoma kinase-positive adenocarcinoma of lung: a cytopathologic analysis].
    Chen Y; Gao L; Wang Y; Gui X; Zhang H; Wang L; Gu L; Feng L; Wu J; Yang W; Song Y; Zeng H; Zhang J; Bai Q; Zhou X; Ping B
    Zhonghua Bing Li Xue Za Zhi; 2015 Sep; 44(9):628-32. PubMed ID: 26705277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Next-generation sequencing and clinical outcomes of patients with lung adenocarcinoma treated with stereotactic body radiotherapy.
    Cassidy RJ; Zhang X; Patel PR; Shelton JW; Escott CE; Sica GL; Rossi MR; Hill CE; Steuer CE; Pillai RN; Ramalingam SS; Owonikoko TK; Behera M; Force SD; Fernandez FG; Curran WJ; Higgins KA
    Cancer; 2017 Oct; 123(19):3681-3690. PubMed ID: 28608966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody 1A4 with routine immunohistochemistry demonstrates high sensitivity for ALK rearrangement screening of Chinese lung adenocarcinoma patients: A single-center large-scale study.
    Wang Q; Zhao L; Yang X; Wei S; Zeng Y; Mao C; Lin L; Fu P; Lyu L; Li Z; Xiao H
    Lung Cancer; 2016 May; 95():39-43. PubMed ID: 27040850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of recurrent FGFR3 fusion genes in lung cancer through kinome-centred RNA sequencing.
    Majewski IJ; Mittempergher L; Davidson NM; Bosma A; Willems SM; Horlings HM; de Rink I; Greger L; Hooijer GK; Peters D; Nederlof PM; Hofland I; de Jong J; Wesseling J; Kluin RJ; Brugman W; Kerkhoven R; Nieboer F; Roepman P; Broeks A; Muley TR; Jassem J; Niklinski J; van Zandwijk N; Brazma A; Oshlack A; van den Heuvel M; Bernards R
    J Pathol; 2013 Jul; 230(3):270-6. PubMed ID: 23661334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [ALK protein expression and gene fusion in bronchoscopic specimens of lung adenocarcinoma].
    Liang X; Wang M; Zhang J; Luo Y; Zhang S; Wu S; Liu Y; Zeng X
    Zhonghua Zhong Liu Za Zhi; 2014 Jul; 36(7):501-4. PubMed ID: 25327654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant expression of anaplastic lymphoma kinase in lung adenocarcinoma: Analysis of circulating free tumor RNA using one-step reverse transcription-polymerase chain reaction.
    Bruno R; Giordano M; Giannini R; Alì G; Puppo G; Ribechini A; Chella A; Fontanini G
    Mol Med Rep; 2016 Sep; 14(3):2238-42. PubMed ID: 27430882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [To evaluate the clinicopathologic characteristics and outcome of tumor cells spreading through air spaces in patients with adenocarcinoma of lung].
    Sun PL; Liu JN; Cao LQ; Yao M; Gao HW
    Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):303-308. PubMed ID: 28468034
    [No Abstract]   [Full Text] [Related]  

  • 35. Copy number gain in recurrent anaplastic lymphoma kinase (ALK) rearrangement-lung adenocarcinoma in the pleural effusion.
    Abe H; Kawahara A; Azuma K; Murakami Y; Takase Y; Naito Y; Akiba J
    Diagn Cytopathol; 2018 Sep; 46(9):744-747. PubMed ID: 29637735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anaplastic Lymphoma Kinase Testing: IHC vs. FISH vs. NGS.
    Niu X; Chuang JC; Berry GJ; Wakelee HA
    Curr Treat Options Oncol; 2017 Nov; 18(12):71. PubMed ID: 29143897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different histopathology but the same clonality: ALK rearrangement in a patient with metastatic non-small-cell lung cancer.
    Zhao J; Zhou J; Chen Z; Wang B; Zhang X; Zhou J; Ding W
    Int J Clin Exp Pathol; 2015; 8(3):3344-8. PubMed ID: 26045865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intratumoral Heterogeneity of ALK-Rearranged and ALK/EGFR Coaltered Lung Adenocarcinoma.
    Cai W; Lin D; Wu C; Li X; Zhao C; Zheng L; Chuai S; Fei K; Zhou C; Hirsch FR
    J Clin Oncol; 2015 Nov; 33(32):3701-9. PubMed ID: 26416997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinicopathological features of lung adenocarcinoma harboring anaplastic lymphoma kinase rearrangements].
    Dong Y; Zhou L; Wang J; Cai Y; Mu J; Zhang H
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):436-40. PubMed ID: 26463147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A standardized protocol for detection of ALK protein expression and gene fusion in lung adenocarcinoma cytologic specimens].
    Wang Z; Wu X; Shi Y; Han X; Cheng G; Li L; Mu X; Zhang Y; Cui D; Zhang L; Fan Z; Zhu G; Ma L; Yang L; Di J; Liu D
    Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):742-8. PubMed ID: 26813592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.